Result of AGM

JPMorgan Emerging Mkts Invest Trust
08 November 2023
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN EMERGING MARKETS INVESTMENT TRUST PLC

 

ANNUAL GENERAL MEETING 2023

RESULT OF POLL AT ANNUAL GENERAL MEETING

 

Legal Entity Identifier: 5493001VPQDYH1SSSR77

Information disclosed in accordance with LR 9.6.18

 

Following the Annual General Meeting of the Company, which was held today, the Board is pleased to announce that all of the Ordinary Business put to shareholders was voted on by poll and passed. In addition, the following items of special business was also voted on by poll and passed which:

 

 

i)          will allow the Company to allot new shares up to an aggregate nominal amount of £2,850,845, representing 10% of the Company's issued share capital;

 

ii)         will allow the disapplication of pre-emption rights on the allotment of new Ordinary shares and by way of a sale of Treasury shares;

 

iii)        to allow the Company to make market purchases of up to 170,936,679 Ordinary shares representing 14.99% of the Company's issued share capital; and

 

iv)        to allow a general meeting, other than an Annual General Meeting, to be called on not less than 14 clear days' notice.

 

The full text of all the resolutions can be found in the Notice of Annual General Meeting contained in the Annual Report and Financial Statements which is available for viewing at the National Storage Mechanism which can be located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and from the Company's website, www.jpmemergingmarkets.co.uk 

The full results of the polls conducted at today's meeting will shortly be available on the Company's website.

 

8th November 2023

 

For further information, please contact:

Alison Vincent

For and on behalf of

JPMorgan Funds Limited, Secretary

0800 20 40 20 (or +44 1268 44 44 70)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings